Results 111 to 120 of about 5,934 (217)

NATURALIZING PSYCHEDELIC SPIRITUALITY

Zygon, 2017
A pressing philosophical problem is how to respond to the existential, anxiety and disenchantment resulting from a naturalistic worldview that eschews transcendent foundations for meaning and value.
doaj   +2 more sources

Lysergic acid diethylamide and mutation [PDF]

Hereditas, 2009
openaire   +2 more sources

Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives

Exploration of Neuroscience
Chronic neuropathic pain is a significant public health issue affecting an estimated 1.5 billion individuals worldwide. The mechanisms underlying chronic pain are multifaceted and not fully understood.
Bushra Yasin, Shivani Mehta, George Tewfik, Alex Bekker   +3 more
doaj   +1 more source

Lysergic Acid Diethylamide Alters the Effects of Brain Stimulation in Rodents. [PDF]

Psychedelic Med (New Rochelle), 2023
Dwiel L, Henricks A, Bragg E, Nicol J, Gui J, Doucette W.   +5 more
europepmc   +1 more source

Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial

BMC Neuroscience
Background Microdosing psychedelics is a phenomenon with claimed cognitive benefits that are relatively untested clinically. Pre-clinically, psychedelics have demonstrated enhancing effects on neuroplasticity, which cannot be measured directly in humans,
Robin J. Murphy, Kate Godfrey, Alexander D. Shaw, Suresh Muthukumaraswamy, Rachael L. Sumner   +4 more
doaj   +1 more source

Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans. [PDF]

Psychol Med, 2023
Kanen JW, Luo Q, Rostami Kandroodi M, Cardinal RN, Robbins TW, Nutt DJ, Carhart-Harris RL, den Ouden HEM.   +7 more
europepmc   +1 more source

Lysergic acid diethylamide stimulates cardiac human H2 histamine and cardiac human 5-HT4-serotonin receptors [PDF]

Lysergic acid diethylamide (LSD) is an artificial hallucinogenic drug. Thus, we hypothesized that LSD might act 5-HT4 serotonin receptors and/or H2 histamine receptors.
Jacob, Hannes, Fehse, Charlotte, Braekow, Pauline, Hofmann, Britt, Kirchhefer, Uwe, Gergs, Ulrich, Pockes, Steffen, Humphrys, Laura J., Neumann, Joachim   +8 more
core   +1 more source

Contextual and experiential aspects of the psychedelic experience predicting improvement in subjective wellbeing: results from a Norwegian internet convenience sample

Frontiers in Pharmacology
BackgroundInterest in the therapeutic effects of classical psychedelics has risen recently. However, little epidemiological knowledge exists about the use of classical psychedelics in Scandinavian countries. Additionally, there is a limited understanding
Paula Aarseth Tunstad, Tor-Morten Kvam, Tor-Morten Kvam, Malin V. Uthaug, Malin V. Uthaug, Lowan H. Stewart, Kristoffer A. A. Andersen, Cato Grønnerød   +7 more
doaj   +1 more source

The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review. [PDF]

CNS Drugs, 2023
Pouyan N, Younesi Sisi F, Kargar A, Scheidegger M, McIntyre RS, Morrow JD.   +5 more
europepmc   +1 more source

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology

, 2016
d-Lysergic Acid Diethylamide (LSD) is known for its hallucinogenic properties and psychotic-like symptoms, especially at high doses. It is indeed used as a pharmacological model of psychosis in preclinical research.
Stefano Comai, Luca Posa, Danilo De Gregorio, Gabriella Gobbi   +3 more
core   +1 more source